Grace Brenner
Family · Nashville, TNNPI 1609641570
Payments from drug & device makers
Across 77 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$296
- AbbVie$264
- AstraZeneca$234
- Astellas Pharma US Inc$123
- Sumitomo Pharma America, Inc.$87
- Otsuka America Pharmaceutical, Inc.$68
- plus $447 from 14 others
What the payments were for
- Food & beverage$1,520100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 15 | $296 |
| AbbVie | 10 | $264 |
| AstraZeneca(2 entities) | 14 | $234 |
| Astellas Pharma US Inc | 6 | $123 |
| Sumitomo Pharma America, Inc. | 5 | $87 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Bayer | 3 | $59 |
| Pfizer | 3 | $50 |
| GSK | 2 | $47 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Exact Sciences | 2 | $30 |
| Lilly USA, LLC | 2 | $29 |
| Ascendis Pharma Endocrinology Inc | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Amgen | 1 | $20 |
| Tolmar, Inc. | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
| Antares Pharma, Inc. | 1 | $16 |
How this compares
$1,520 in reported general payments places this provider in the 70th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 53 | $69,750 |
| JardianceEmpagliflozin | 22 | $32,481 |
| MounjaroTirzepatide | 19 | $21,879 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $16,293 |
| FarxigaDapagliflozin Propanediol | 11 | $12,378 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $1,510 |
| PaxlovidNirmatrelvir/Ritonavir | 11 | $1,429 |
| Duloxetine Hcl | 13 | $1,212 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $906 |
| Atorvastatin Calcium | 68 | $787 |
| Gabapentin | 40 | $660 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $619 |
| Fluticasone Propionate | 35 | $588 |
| Omeprazole | 31 | $516 |
| Bupropion XlBupropion Hcl | 14 | $498 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $296 | $69,75053 claims |
| Lilly USA, LLCMounjaro | $29 | $21,87919 claims |
| GSKTrelegy Ellipta | $47 | $16,29324 claims |
| AstraZenecaFarxiga | $234 | $12,37811 claims |
| PfizerPaxlovid | $50 | $1,42911 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $18 | $44952 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,706 family providers in Tennessee.
Other family in Nashville
- Tamera ThoenerNashville$254K
- Jennifer WilliamsNashville$213K
- Lori LankfordNashville$148K
- Melissa RikalNashville$144K
- Nicole DelliseNashville$67K
- Lesley BallanceNashville$63K
- Jeffrey WoodsNashville$38K
- Courtney HavillNashville$35K
- Collette UtleyNashville$28K
- Stacy BrownMt Juliet$719K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.